{
  "id": 10966177,
  "title": "Could This Company Challenge Eli Lilly and Novo Nordisk in the Weight Loss Market?",
  "url": "https://urgent.news/2026/09/30/could-this-company-challenge-eli-lilly-and-novo-nordisk-in-the-weight-10966177",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-30T14:44:01.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/could-company-challenge-eli-lilly-and-novo-nordisk-weight-loss-market"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsRoche's leading weight loss and diabetes candidate has posted excellent Phase 2 clinical trial results.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Could This Company Challenge Eli Lilly and Novo Nordisk in the Weight Loss Market?",
        "url": "https://urgent.news/2026/09/30/could-this-company-challenge-eli-lilly-and-novo-nordisk-in-the-weight",
        "published": "2026-09-30T14:24:01.000Z"
      },
      {
        "outlet": "Nasdaq Markets",
        "title": "Lilly Just Reported More Than Half of Patients on Its New Weight Loss Drug Lost 20% of Their Body Weight — and a Third Lost 25%. Here's How the News Could Shake Up the Obesity Drug Market.",
        "url": "https://urgent.news/2026/09/30/lilly-just-reported-more-than-half-of-patients-on-its-new-weight-loss-10989345",
        "published": "2026-09-30T16:24:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}